Status:
UNKNOWN
Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Advanced Glaucoma
Refractory Glaucoma
Eligibility:
All Genders
22+ years
Phase:
PHASE1
PHASE2
Brief Summary
The aim of this study is to compare the safety and efficacy of conventional and micropulse transscleral diode laser in the treatment of end-stage glaucoma.
Detailed Description
End-stage glaucoma is difficult to treat, and it may sometimes be unresponsive to surgery or medications. A common treatment is the conventional transscleral cyclophotocoagulaion, but it has various s...
Eligibility Criteria
Inclusion
- · More than 21 years old
- Advanced glaucoma refractory to maximum tolerated medical and surgical treatment
- Visual acuity worse than 6/60
- Poor candidates for additional filtration surgery
Exclusion
- · Any eye surgery done within 2 months of enrolment
- Any ocular infection or inflammation
- Unable to give informed consent
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00349414
Start Date
July 1 2006
End Date
December 1 2008
Last Update
May 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital Singapore Department of Ophthalmology
Singapore, Singapore, 119074